Hla
Phone Maw Hla, Singapore SG
Patent application number | Description | Published |
---|---|---|
20140113410 | SYSTEM IN PACKAGE MANUFACTURING METHOD USING WAFER-TO-WAFER BONDING - Embodiments of the present disclosure are related to manufacturing system-in-packages at wafer-level. In particular, various embodiments are directed to adhering a first wafer to a second wafer and adhering solder balls to contact pads of the first wafer. In one embodiment, a first wafer having first and second surfaces is provided. The first wafer includes bond pads located on the first surface that are coupled to a respective semiconductor device located in the first wafer. A second wafer having an electrical component located therein is provided. A conductive adhesive is provided on at least one of the first wafer and the second wafer. Conductive balls are provided on the bond pads on the first surface of the first wafer. The conductive balls and the conductive adhesive are heated to cause the conductive balls to adhere to the bond pad and the conductive adhesive to adhere the first wafer to the second wafer. | 04-24-2014 |
Saw Wai Hla, Athens, OH US
Patent application number | Description | Published |
---|---|---|
20130040822 | Engineering of an Ultra-Thin Molecular Superconductor by Charge Transfer - A method of forming a superconductive device of a single layer of (BETS) | 02-14-2013 |
Saw-Wai Hla, Chicago, IL US
Patent application number | Description | Published |
---|---|---|
20140259235 | SIMULTANEOUS TOPOGRAPHIC AND ELEMENTAL CHEMICAL AND MAGNETIC CONTRAST IN SCANNING TUNNELING MICROSCOPY - A method and system for performing simultaneous topographic and elemental chemical and magnetic contrast analysis in a scanning, tunneling microscope. The method and system also includes nanofabricated coaxial multilayer tips with a nanoscale conducting apex and a programmable in-situ nanomanipulator to fabricate these tips and also to rotate tips controllably. | 09-11-2014 |
Timothy Hla, Avon, CT US
Patent application number | Description | Published |
---|---|---|
20110015159 | METHODS OF INHIBITING VASCULAR PERMEABILITY AND APOPTOSIS - Agonists of vascular endothelial sphingosine-1-phosphate receptors are described. Compounds such as FTY720 can be phosphorylated by sphingosine kinase-2 into the phosphorylated forms which serve as sphingosine-1-phosphate receptor agonists. The vascular endothelial sphingosine-1-phosphate receptor agonists are employed in methods of treating a mammal for vascular permeability disorders and unwanted vascular endothelial cell apoptosis, and for the growth of new blood vessels. The sphingosine-1-phosphate receptor agonists can be used for the manufacture of a medicament for treating vascular permeability disorders and unwanted vascular endothelial cell apoptosis, and for the growth of new blood vessels. | 01-20-2011 |
20140303086 | ENDOTHELIUM PROTECTIVE MATERIALS AND METHODS OF USE - Apolipoprotein M forms a complex with sphingosine-1-phosphate (S1P) and is the carrier of S1P in high density lipoprotein particles and mediates its endothelial protective effect. Increasing the concentration of the apoM/S1P complex by administering it, either alone or in HDL particles, can prevent or treat diseases caused by endothelial cell injury, including inflammatory diseases, sepsis, atherosclerosis and acute lung injury, ischemic heart disease, stroke, vital organ failure after ischemic stress. | 10-09-2014 |
Timothy Tun Hla, Avon, CT US
Patent application number | Description | Published |
---|---|---|
20090004207 | Methods and Compositions for Inhibiting Pathological Angiogenesis in the Eye - Disclosed herein are compositions and methods for inhibiting abnormal angiogenesis in the eye, particularly in the retina. The methods include administering to subject in need of treatment for pathological angiogenesis of the eye a pharmaceutically effective amount of an inhibitor of the receptor activity of the S1P2 receptor. Also included are compositions including an S1P2 receptor antagonist and an opthalmically acceptable excipient. | 01-01-2009 |
20100068200 | Methods and Compositions for Inhibiting Atherosclerosis and Vascular Inflammation - Disclosed herein are compositions and methods for reducing inflammation associated with atherosclerosis and/or vascular inflammatory disease. The methods include administering to a subject in need of treatment for atherosclerosis and/or vascular inflammation a pharmaceutically effective amount of an inhibitor of the receptor activity of the S1P2 receptor. Also included are compositions including an S1P2 receptor antagonist and a pharmaceutically acceptable excipient. | 03-18-2010 |